DXRX — Diaceutics Cashflow Statement
0.000.00%
Last trade - 00:00
- £87.66m
- £71.04m
- £19.50m
- 82
- 22
- 82
- 70
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.877 | 0.497 | -0.682 | 0.462 | 0.564 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.607 | 0.11 | 0.067 | 0.292 | 0.461 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.56 | -1.52 | 0.059 | -1.98 | 1.06 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.954 | -0.63 | 0.253 | 0.57 | 5.1 |
Capital Expenditures | -1.11 | -2.93 | -6.29 | -5.6 | -4.87 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.003 | 0 | — | 0.111 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.11 | -2.92 | -6.29 | -5.6 | -4.76 |
Financing Cash Flow Items | -0.602 | -0.248 | 0 | -0.056 | -0.059 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.05 | 13.3 | 19.6 | -0.27 | -0.191 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.995 | 9.65 | 13.5 | -5.58 | 0.166 |